The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men
✍ Scribed by Fabiana B. Kohlrausch; Rita De Cássia Estrela; Paulo F. Barroso; Guilherme Suarez-Kurtz
- Book ID
- 108642420
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 381 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0306-5251
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Highly active antiretroviral therapy (HAART) has improved the life expectancy of HIV-infected patients, allowing orthotopic liver transplantation as a reasonable treatment option for selected patients with terminal liver disease. Both non-nucleoside reverse transcriptase inhibitors and protease inhi
A linkage disequilibrium (LD) between the alcohol-dehydrogenase 1B (ADH1B) and alcohol-dehydrogenase 1C (ADH1C) polymorphisms adds complexity to differentiating the significance of these two genetic polymorphisms on drinking behavior and alcoholism. We have recently shown the importance of the ADH1B
Plasma levels of HIV protease inhibitors (PI) are often close to IC50 values of wild-type viruses when administered without ritonavir boosting. The impact of drug levels, resistance mutations, and the genotypic inhibitory quotient (GIQ) were examined on the response to saquinavir/ritonavir (SQV/r)-b